Skip to main content
Equibles

Aberdeen Group plc

Position in IMVT — Immunovant, Inc.

CIK 1716774 EDINBURGH, X0
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$33,021,365
+$4,188,037 QoQ
Shares Held
857,030
-26.2% QoQ
Ownership
0.415%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#26
of 226 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. IMVT ranks #18 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MANE
Veradermics, Inc
 1,096,642 $134,821,167
2 QURE
uniQure N.V.
 2,848,117 $131,184,269
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 210,601 $104,611,833
4 ARGX
Argenx SE
 83,822 $77,767,536
5 ABVX
Abivax S.A.
 522,025 $69,565,051
6 REGN
Regeneron Pharmaceuticals, Inc.
 101,566 $63,330,462
7 ORKA
Oruka Therapeutics, Inc.
 646,943 $61,569,565
8 INSM
INSMED Inc
 577,437 $61,566,331

All Filings in IMVT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,021,365 857,030
2026-03-31 $28,833,328 1,160,762
2025-12-31 $30,100,381 1,184,122
2025-09-30 $15,826,680 981,804
2025-06-30 $13,515,280 844,705
2025-03-31 $14,004,861 819,477
2024-12-31 $13,180,364 532,110
2024-09-30 $13,649,362 478,757
2024-06-30 $10,579,060 400,722
2024-03-31 $6,062,519 187,636
2023-12-31 $13,806,253 327,706